Articles in section Mergers & Acquisitions
| << Licensing | 703 articles | Opinion & Analysis >> |
| Pages 1 2 3 4 5 .. 71 | Next >> |
-
BioMarin Expands Rare Disease Portfolio with US$4.8 B Acquisition of Amicus Therapeutics
-
Merck Expands Respiratory Portfolio with US$9.2 B Acquisition of Cidara Therapeutics
-
Novartis to Acquire Neuromuscular Specialist Avidity Biosciences for US$12 B
-
Bristol Myers Squibb to Acquire Orbital Therapeutics and its RNA Platform for US$1.5 B
-
Genmab Strengthens Oncology Pipeline with US$8 B Acquisition of Merus
-
Novo Nordisk Strengthens Metabolic Pipeline with US$5.2 B Acquisition of Akero Therapeutics
-
BioCryst to Acquire Astria Therapeutics for up to US$700 M
-
Roche to Acquire 89bio and its FGF21 Analogue Lead Asset for US$3.5 B
-
Pfizer Expands Obesity Portfolio with US$4.9 B Acquisition of Metsera
-
AbbVie to Acquire Gilgamesh’s Psychedelic Depression Treatment for US$1.2 B
RSS